Rafferty Asset Management’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-56,057
| Closed | -$1.64M | – | 1269 |
|
|
2021
Q4 | $1.64M | Buy |
56,057
+27,100
| +94% | +$795K | 0.01% | 729 |
|
|
2021
Q3 | $1.9M | Buy |
28,957
+3,262
| +13% | +$214K | 0.01% | 652 |
|
|
2021
Q2 | $2.14M | Sell |
25,695
-12,242
| -32% | -$1.02M | 0.01% | 670 |
|
|
2021
Q1 | $2.91M | Buy |
37,937
+31,672
| +506% | +$2.43M | 0.02% | 514 |
|
|
2020
Q4 | $553K | Sell |
6,265
-2,186
| -26% | -$193K | 0.01% | 660 |
|
|
2020
Q3 | $624K | Buy |
8,451
+5,198
| +160% | +$384K | 0.01% | 658 |
|
|
2020
Q2 | $237K | Buy |
+3,253
| New | +$237K | ﹤0.01% | 881 |
|